Hyperpigmentation is one of the most common reasons people reach for red light therapy, and it is also one of the trickiest to get right. The honest answer is that red and near-infrared light can fade some dark spots while, under the wrong conditions, making others worse. This review walks through the mechanism, the actual clinical evidence by pigment type, the wavelength and heat traps that matter most for darker skin, and how red light stacks up against treatments with far stronger track records.
What "Hyperpigmentation" Actually Means
"Dark spots" is a catch-all term for several different problems, and they do not respond to light the same way. Lumping them together is the single biggest reason people get confused about red light therapy.
The main categories you will run into:
- Post-inflammatory hyperpigmentation (PIH). Brown or gray marks left behind after acne, a bug bite, a burn, or a cosmetic procedure. The trigger is inflammation, and the pigment can sit in the epidermis (surface), the dermis (deeper), or both.
- Melasma. Symmetrical brown or gray-brown patches, usually on the cheeks, forehead, and upper lip. It is driven by a tangle of hormones, sunlight, visible light, and heat. Melasma is chronic, relapses easily, and is famously stubborn.
- Sun spots (solar lentigines). Flat, well-defined brown spots from years of UV exposure. Common on the face, hands, and chest.
- Freckles (ephelides). Genetic, sun-activated, usually harmless.
These behave differently because the pigment lives at different depths and is driven by different triggers. A surface PIH spot fading after your acne clears is a very different scenario from melasma, where the melanocytes are essentially "trigger-happy" and react to heat and light themselves.
This distinction matters because the same red light device can be neutral-to-helpful for one type and risky for another. If you only remember one thing from this article: melasma is the special case, and it is the type most likely to get worse.
How Red Light Is Supposed to Affect Pigment
Red light therapy, also called photobiomodulation (PBM), uses LEDs in the red (around 630 to 660 nm) and near-infrared (around 800 to 850 nm) range. Unlike a laser, it does not destroy pigment with heat. Instead, the light is absorbed by mitochondria inside skin cells, which can nudge cellular behavior.
For pigmentation, two competing effects are in play, and both are real.
The fading side. Red and near-infrared light can lower the activity of tyrosinase, the key enzyme that builds melanin. It may also reduce inflammation, calm the redness and broken capillaries that often accompany melasma, and speed up the turnover of skin already carrying excess pigment. The integrative review on PBM for melasma found that specific wavelengths produced "modulatory effects on tyrosinase activity, gene expression, and protein synthesis" and could "significantly reduce the melanin content." That is a genuine, plausible pathway to lighter spots.
The darkening side. The same light energy that boosts mitochondrial activity can, in some people, overstimulate melanocytes or generate oxidative stress. When the skin's antioxidant defenses get overwhelmed, the result can be more pigment, not less. This is not theoretical. Case reports document pigment darkening from red light alone, not just from infrared or heat.
So the mechanism cuts both ways. Whether you fade or darken depends on your pigment type, your skin tone, the device's heat output, and the dose. There is no single "red light fades dark spots" rule that holds across the board.
You can read more about the underlying cellular science in our guide on red light therapy for skin and the breakdown of red light therapy wavelengths explained.
The Evidence, Graded Honestly
This is where most marketing falls apart. The studies are small, the protocols are clinical (not at-home), and the evidence level is low. Here is what actually exists, broken down by pigment type.
Melasma: promising but low-quality evidence
Melasma has the most published PBM research, and the headline results look good on paper.
A 2018 split-face pilot study by Barolet used pulsed 940 nm near-infrared light on seven women with stubborn dermal melasma. The treated side dropped from a baseline MASI score of 11.4 to 4.7 by week 12 (p < 0.001), roughly a 59 percent improvement over the untreated control side. The authors also reported a "preconditioning" effect that seemed to make skin more resistant to future UV exposure.
A 2024 integrative review pulled together the PBM-for-melasma literature. It concluded that red (630 nm), amber (585 to 590 nm), and infrared (830 to 850 nm) light at doses of 1 to 20 J/cm² showed modulatory effects on melanin production and called PBM "a promising, contemporary, and non-invasive procedure." But the same review was blunt about the limits: the evidence is held back by small samples, missing control groups, and no agreement on optimal settings. Its own conclusion calls for "robust and well-designed clinical trials."
Translation: encouraging signal, weak proof. A seven-person pilot is a starting point, not a verdict. And critically, these were supervised clinical protocols with carefully controlled doses, not someone holding a hot LED mask to their face every night.
Post-inflammatory hyperpigmentation: thin, indirect evidence
PIH has surprisingly little direct red light research. Most of what gets cited is extrapolated from two places: red light's known ability to calm acne-related inflammation (which can prevent new PIH from forming), and general anti-inflammatory effects. The logic is reasonable: less inflammation now means fewer dark marks later. But "may help prevent" is not the same as "fades existing spots," and the direct evidence for clearing established PIH with red light is sparse and low quality.
There is a second wrinkle worth naming. Whether PIH fades at all depends heavily on where the pigment sits. Epidermal (surface) PIH tends to clear on its own over weeks to months, so any device used during that window can look more effective than it really is, simply because the spot was going to fade anyway. Dermal PIH, where pigment has dropped into the deeper layer, is far more stubborn and resists almost everything, including light. Without a controlled study isolating red light from natural fading, it is hard to know how much credit the device actually deserves. That is exactly the gap the existing research has not filled.
Sun spots and freckles: essentially no good evidence
Red light therapy is not a meaningful treatment for solar lentigines or freckles. These respond best to targeted approaches like lasers, intense pulsed light, and topical retinoids and tyrosinase inhibitors. If a device markets itself as fading "sun spots," treat that as a stretch.
Here is the evidence at a glance:
| Pigment type | Direct red light evidence | Quality | Realistic expectation |
|---|---|---|---|
| Melasma | A few small pilots + one review | Low (small N, few controls) | Possible modest fading in supervised protocols; high relapse risk |
| Post-inflammatory hyperpigmentation | Mostly indirect (via acne/inflammation) | Low | May help prevent new PIH; weak for fading old marks |
| Sun spots (lentigines) | Minimal | Very low | Not a primary treatment |
| Freckles | None meaningful | None | No reason to expect benefit |
For a deeper dive into the melasma-specific literature, see our red light therapy and melasma dermatology study review.
The Real Risk: When Red Light Makes It Worse
This is the part the glossy device ads skip. For melasma and for darker skin tones, red light therapy carries a genuine risk of backfiring. Three factors drive it.
1. Heat
Melasma is heat-sensitive. Melanocytes in melasma-prone skin react to warmth, which is why standing over a hot stove or sitting in a sauna can flare it. Many cheap, high-power LED masks and panels run warm. If a device heats your skin meaningfully, it can aggravate melasma regardless of which wavelength it uses.
There is nuance here. Some science suggests heat alone does not trigger pigment until skin gets quite hot (around 45 °C / 113 °F), and that the bigger culprit is oxidative stress and melanocyte overstimulation. But the practical takeaway is the same: a device that warms your face is a device to be cautious with if you have melasma.
2. Wavelength and visible light
Pigmentation researchers have shown that visible light can induce melanogenesis, especially in darker skin. A 2010 study demonstrated that visible light induces skin darkening in Fitzpatrick types IV through VI but not in lighter skin, and that the effect depends on how much melanin the skin already carries. A 2023 study found that repeated low-dose visible light exposure produced lasting pigmentation in dark-skinned (types V to VI) volunteers while leaving light-skinned individuals largely unaffected.
The important detail: most of that melanogenic punch comes from the shorter, higher-energy end of visible light (blue and violet, the so-called high-energy visible or HEV range), not from longer-wavelength red light. Red sits at the low-energy end of the spectrum. That is the theoretical reason red is considered gentler than blue for pigmentation, and why near-infrared is often described as "bypassing" epidermal melanin. But many consumer LED masks emit blue, red, and near-infrared, sometimes all at once. If you are melasma-prone and your mask runs blue cycles, that is a real concern.
3. Skin tone and dose
The risk is concentrated in Fitzpatrick types IV through VI. Melanin-rich skin reacts more strongly to light, so the same dose that is neutral on pale skin can darken deeper skin. Overdoing sessions, stacking devices, or combining light with abrasive scrubs raises the odds further. One small pilot noted a participant whose pigment darkened, possibly tied to concurrent scrubbing.
| Risk factor | Why it matters | Who should be most careful |
|---|---|---|
| Device heat | Warmth can flare heat-sensitive melasma | Anyone with melasma |
| Blue / HEV light in the device | Higher-energy visible light drives melanogenesis | Darker skin tones, melasma |
| Darker skin (Fitzpatrick IV-VI) | More melanin reacts more strongly to light | Skin types IV, V, VI |
| Overuse / stacking / scrubbing | Oxidative stress and irritation cause rebound pigment | Everyone, especially the above |
For the broader risk picture, see our guide on red light therapy side effects.
How Red Light Compares to Proven Treatments
If your goal is fading dark spots, red light is, at best, a minor supporting player. Here is the honest competitive landscape.
| Treatment | Evidence strength | Best for | Notes |
|---|---|---|---|
| Sun protection (broad-spectrum SPF + iron oxide) | Strong | All pigmentation, melasma especially | Foundation of every protocol; iron oxide blocks visible light |
| Tyrosinase inhibitors (hydroquinone, azelaic acid, tranexamic acid) | Strong | Melasma, PIH | First-line topicals; hydroquinone is the classic gold standard |
| Retinoids (tretinoin) | Strong | PIH, photoaging, melasma (in combos) | Boosts turnover; often part of triple-combination cream |
| Chemical peels | Moderate to strong | PIH, melasma, lentigines | Operator-dependent; risk of PIH if too aggressive |
| Lasers / IPL | Moderate to strong | Lentigines, some melasma | Powerful but can worsen melasma if misused |
| Red light therapy (PBM) | Low | Adjunct only | Small pilots; may complement, rarely a standalone fix |
The single most important line in this table is the first one. Both the American Academy of Dermatology and the melasma research consistently put sun protection first. The AAD states plainly that "sunlight causes the skin to make more pigment, which can darken existing melasma and cause new patches," and recommends broad-spectrum SPF 30 or higher with zinc oxide, titanium dioxide, or iron oxide. Tinted, iron-oxide sunscreens matter specifically because they block the visible light that ordinary SPF lets through, and studies link them to fewer melasma relapses.
It is worth sitting with the irony here. The same visible light that some research suggests can darken melasma-prone skin is exactly what a tinted, iron-oxide sunscreen is designed to block, with reported visible-light attenuation rates above 90 percent in tinted formulas. So while you are weighing whether a red light device might help your pigment by a few points, the cheap tube of iron-oxide SPF in the drugstore has stronger evidence behind it and protects you from the visible-light exposure you get all day from screens and windows. If you can only do one thing for dark spots, it is not buying a light panel. It is wearing tinted sunscreen every single day, indoors and out.
The AAD also describes light and laser treatments as adjunctive, noting only that "a few studies have found that adding a laser or light treatment can improve results" alongside medication and sun protection, and that procedures should be done by a board-certified dermatologist. That is the right altitude for red light too: a possible add-on, not a cure.
Safety and Smart Use
If you still want to try red light for pigmentation, here is how to lower the odds of making things worse.
- See a dermatologist first if you have melasma. This is the one type where DIY light can backfire, and a pro can tell you whether your pigment is epidermal or dermal, which changes the game plan.
- Pick a low-heat device. If a mask or panel warms your skin noticeably, it is the wrong tool for melasma-prone skin.
- Favor red and near-infrared; be wary of blue cycles. Higher-energy visible light is the bigger melanogenesis driver. If you have darker skin or melasma, skip blue.
- Start low and slow. Shorter sessions, fewer per week, and stop if you see any darkening. Track with photos in consistent lighting.
- Never skip sunscreen. Iron-oxide tinted SPF is non-negotiable for melasma. Red light without sun protection is a losing game.
- Do not stack aggressive treatments. Avoid combining light with scrubs, strong acids, or fresh procedures unless a clinician okays it.
- Set realistic timelines. Melasma improvement takes months, and relapse is the norm. The AAD notes results can take 3 to 12 months even with proven treatments.
Curious how light interacts with your other actives? See red light therapy with retinol and tretinoin: how to combine safely.
Who It's For (and Who Should Skip It)
Reasonable candidates:
- People with lighter skin (Fitzpatrick I to III) and mild, surface-level pigment who want a low-risk adjunct.
- Acne-prone folks using red light mainly to calm breakouts, with PIH prevention as a side benefit.
- Anyone already under a dermatologist's care who wants to layer PBM onto a proven regimen.
People who should be cautious or skip it:
- Anyone with active melasma, especially with darker skin. The risk-reward here is genuinely unfavorable without professional guidance.
- People expecting red light to erase sun spots or freckles. It will not.
- Anyone hoping to replace sunscreen, retinoids, or tyrosinase inhibitors with a light device. That is the wrong trade.
The realistic verdict: red light therapy is a low-evidence adjunct for pigmentation. It might help a little, mostly by reducing inflammation and possibly nudging melanin production down. It can also make melasma worse in the wrong skin with the wrong device. It is not a substitute for the boring, proven basics: sun protection, topicals, and dermatologist guidance.
Frequently Asked Questions
Does red light therapy fade dark spots?
Sometimes, modestly, and mostly for certain types. Small clinical studies suggest red and near-infrared light can lower melanin production and improve melasma in supervised settings, and red light may help prevent post-inflammatory hyperpigmentation by calming inflammation. But the evidence is low quality, the effect is small, and it does little for sun spots or freckles. It is an adjunct, not a primary treatment.
Can red light therapy make hyperpigmentation worse?
Yes, under specific conditions. The main risks are device heat (which can flare heat-sensitive melasma), blue or high-energy visible light cycles in multi-color devices, and overuse, especially in darker skin (Fitzpatrick IV to VI). Documented case reports show pigment darkening even from red light alone. If you have melasma, talk to a dermatologist before starting.
Is red light therapy safe for melasma?
It is the riskiest pigmentation type for at-home light. Melasma melanocytes react to heat and light themselves, so a warm device or one with blue light can backfire. Some small studies show benefit with carefully dosed clinical protocols, but those are not the same as an unsupervised mask at home. Get professional guidance first.
What wavelength is best for hyperpigmentation?
For pigment safety, longer wavelengths are gentler. Red (around 630 to 660 nm) and near-infrared (around 800 to 850 nm) sit at the low-energy end of the spectrum and are far less likely to drive melanin production than blue or violet light. Near-infrared is often described as bypassing surface melanin. Avoid blue-light cycles if you are melasma-prone or have darker skin.
What works better than red light therapy for dark spots?
Almost everything with strong evidence. Daily broad-spectrum sunscreen with iron oxide is the foundation. Tyrosinase inhibitors like hydroquinone, azelaic acid, and tranexamic acid, plus retinoids such as tretinoin, are first-line. Chemical peels, lasers, and IPL handle stubborn cases. Red light is best viewed as a minor add-on to these, not a replacement.
Disclaimer
This article is for general information only and is not medical advice. Pigmentation disorders, especially melasma, can be unpredictable and require individualized care. Consult a board-certified dermatologist before starting red light therapy or any treatment for dark spots.
Sources
- Galache TR, et al. Photobiomodulation for melasma treatment: Integrative review and state of the art. Photodermatol Photoimmunol Photomed, 2024. PMID 38018017.
- Barolet D. Dual Effect of Photobiomodulation on Melasma: Downregulation of Hyperpigmentation and Enhanced Solar Resistance—A Pilot Study. J Clin Aesthet Dermatol, 2018. PMID 29657669.
- Kim S, et al. Clinical and molecular change induced by repeated low-dose visible light exposure in both light-skinned and dark-skinned individuals. Photodermatol Photoimmunol Photomed, 2023. PMID 35861041.
- Mahmoud BH, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol, 2010. PMID 20410914.
- American Academy of Dermatology. Melasma: Diagnosis and treatment.
- Basit H, et al. Melasma (StatPearls). NCBI Bookshelf.
- PubMed search: photobiomodulation melasma.
- PubMed search: red light therapy hyperpigmentation.